CN106619617A - Melatonin composition and preparation method thereof - Google Patents

Melatonin composition and preparation method thereof Download PDF

Info

Publication number
CN106619617A
CN106619617A CN201611094238.0A CN201611094238A CN106619617A CN 106619617 A CN106619617 A CN 106619617A CN 201611094238 A CN201611094238 A CN 201611094238A CN 106619617 A CN106619617 A CN 106619617A
Authority
CN
China
Prior art keywords
epiphysin
starch
premix
cobastab
magnesium stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611094238.0A
Other languages
Chinese (zh)
Inventor
许震
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUHU NOKAN BIOTECHNOLOGY CO Ltd
Original Assignee
WUHU NOKAN BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUHU NOKAN BIOTECHNOLOGY CO Ltd filed Critical WUHU NOKAN BIOTECHNOLOGY CO Ltd
Priority to CN201611094238.0A priority Critical patent/CN106619617A/en
Publication of CN106619617A publication Critical patent/CN106619617A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a melatonin composition and a preparation method thereof, and belongs to the technical field of health products. In an inventory ration of 1000 grains, the melatonin composition contains the following materials by weight: 2-3.5g of melatonin, 1.5-2.5g of vitamin B6, 80-120g of starch, 200-250g of powdered sugar, 5-9g of silicon dioxide, and 1.5-2.5g of magnesium stearate. By virtue of the composition having the effects of soothing the nerves and improving sleeping and prepared by mixing of the melatonin, the vitamin B6 and the like, disclosed by the invention, the problem of different injuries to a body due to long-time taking of sleeping pills is solved, and the composition has the advantages of improving sleeping, delaying senescence and adjusting immunity.

Description

A kind of epiphysin composition and preparation method thereof
Technical field
The invention belongs to health product technology field, and in particular to a kind of epiphysin composition and preparation method thereof.
Background technology
People has 1/3rd time among all one's life spent in sleep, and not sleeping within five days to die, it is seen that sleep It is the physiological requirements of people, sleeps as process necessary to life, is the important step of body recovery, integration and consolidating memory, It is healthy indispensable part.Sleep refers to the inertia and non-reactiveness of recurrence, during sleep level of consciousness reduction or Disappear, most physiological activity and be reacted into inert condition, by sleep, the nerve cell for making fatigue recovers normal raw Reason function, spirit and muscle power are restored.Anterior pituitary growth hormone secretion substantially increases during sleep, may advantageously facilitate body life It is long, and increase nucleoprotein synthesis, be conducive to the storage remembered.Sleep failure refers to exception and length of one's sleep of sleep quality It is abnormal, or there are some clinical symptoms in sleep, such as sleep is reduced or hypersomnia, somnambulism etc., is affected to fall asleep or is kept The various obstacles of ortho ability, also including hypersomnia, or the behavior of the sleep correlation of exception.Occur sleep failure when Wait, often take the medicine of hypnotic etc, but long-term taking hypnotic has different degrees of injury to human body, such as can Cause liver and kidney failure, in addition long-term taking hypnotic has different degrees of injury to human body, such as can cause liver kidney work( Energy exhaustion, phrenoblabia, or even induction other diseases.
The content of the invention
According to above the deficiencies in the prior art, the technical problem to be solved is to propose a kind of epiphysin composition And preparation method thereof, by mixing epiphysin, Cobastab6Etc. system with the composition calmed the nerves, improve the health care of sleep, length is solved Phase takes the problems that hypnotic causes different injuries to body, has the advantages that to improve the health care of sleep, anti-aging, adjusts immunity.
In order to solve above-mentioned technical problem, the technical solution used in the present invention is:A kind of epiphysin composition, with 1000 Feed intake gauge, comprising following material and its content:Epiphysin 2-3.5g, Cobastab61.5-2.5g, starch 80-120g, Icing Sugar 200-250g, silica 5-9g, magnesium stearate 1.5-2.5g.
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2-2.9g, Cobastab61.5-1.9g, starch 90-105g, Icing Sugar 210-240g, silica 6-8g, magnesium stearate 1.6-2.4g.
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2.8g, dimension Raw element B61.8g, starch 95g, Icing Sugar 240g, silica 8g, magnesium stearate 2.4g.
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2.7g, dimension Raw element B61.9g, starch 98g, Icing Sugar 238g, silica 7.2g, magnesium stearate 2.2g.
A kind of preparation method of epiphysin composition, methods described step includes:
Step one, take epiphysin and Cobastab6Sieve respectively prepared fine powder, and prepared premix is well mixed with silica Material A;Epiphysin and Cobastab6Sieve and use 100 mesh sieves;
Step 2, starch sieve prepared starch dust, and prepared premix B is well mixed by equal increments method with premix A;
Step 3, white sugar sieve prepared Icing Sugar, and 30 minutes prepared premix C are mixed with premix B;
Step 4, take magnesium stearate and mix with premix C 15 minutes, total mixed powder is obtained after being well mixed;
After step 5, the inspection of total mixed powder, send into capsule machine filling and capsule is obtained.
Present invention has the advantages that:Epiphysin, epiphysin enzymatic reaction and non-enzymatic in body is employed herein May produce free radical during reaction, free radical and aging have it is close contact, the effect with anti-aging, epiphysin in addition Can shorten and sleep front awakening time and time for falling asleep, improve the health care of sleep quality, number of times of awakening in sleep is significantly reduced, shallow to sleep the stage short, Deep sleep stages extend, and morning next day threshold wake-up value declines, and have stronger jet lag function and adjust immunologic function, and this product is adapted to Adult is edible, and raw material sources fully, can be produced throughout the year.It may be said that the product integrates nutrition, health care, Dimensions of market is big, and rationally, input and output are high for process design, and high financial profit can have good return rate.
Specific embodiment
Below against by the description to embodiment, the shape of for example involved each component of specific embodiment of the invention Mutual alignment and annexation, the effect of each several part and operation principle, manufacturing process and operation between shape, construction, each several part Using method etc., is described in further detail, to help inventive concept, technical scheme of the those skilled in the art to the present invention There is more complete, accurate and deep understanding.
Embodiment one,
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2-3.5g, Cobastab61.5-2.5g, starch 80-120g, Icing Sugar 200-250g, silica 5-9g, magnesium stearate 1.5-2.5g.
The preparation method of above-mentioned epiphysin composition is:
Step one, take epiphysin and Cobastab6100 mesh sieves are crossed respectively fine powder is obtained, be well mixed with silica prepared Premix A.
Step 2, starch cross 100 sieve series and obtain starch dust, and prepared premix is well mixed by equal increments method with premix A Material B;
Step 3, white sugar cross 100 sieve series and obtain Icing Sugar, and 30 minutes prepared premix C are mixed with premix B;
Step 4, take magnesium stearate and mix with premix C 15 minutes, total mixed powder is obtained after being well mixed;
After step 5, the inspection of total mixed powder, capsule machine is sent into, capsule is obtained with every 0.35g filling, capsule is thrown Light, select and packed after certified products, choose the underproof packaging product of outward appearance in time during inner packing, inner packing (60/ Bottle) after capsule put in storage Jing after external packing, quality inspection.
Embodiment two,
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2-2.9g, Cobastab61.5-1.9g, starch 90-105g, Icing Sugar 210-240g, silica 6-8g, magnesium stearate 1.6-2.4g.
Embodiment three,
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2.8g, dimension Raw element B61.8g, starch 95g, Icing Sugar 240g, silica 8g, magnesium stearate 2.4g.
Example IV,
A kind of epiphysin composition, with 1000 gauge that feed intake, comprising following material and its content:Epiphysin 2.7g, dimension Raw element B61.9g, starch 98g, Icing Sugar 238g, silica 7.2g, magnesium stearate 2.2g.
Above in conjunction with being exemplarily described to the present invention, it is clear that the present invention is implemented and do not limited by aforesaid way System, if the improvement of the various unsubstantialities that method of the present invention design and technical scheme are carried out is employed, or not improved general The design and technical scheme of the present invention directly applies to other occasions, within protection scope of the present invention.The present invention's The protection domain that protection domain should be limited by claims is defined.

Claims (6)

1. a kind of epiphysin composition, it is characterised in that with 1000 gauge that feed intake, comprising following material and its content:Take off black Plain 2-3.5g, Cobastab61.5-2.5g, starch 80-120g, Icing Sugar 200-250g, silica 5-9g, magnesium stearate 1.5- 2.5g。
2. epiphysin composition according to claim 1, it is characterised in that with 1000 gauge that feed intake, comprising following thing Matter and its content:Epiphysin 2-2.9g, Cobastab61.5-1.9g, starch 90-105g, Icing Sugar 210-240g, silica 6- 8g, magnesium stearate 1.6-2.4g.
3. epiphysin composition according to claim 1, it is characterised in that with 1000 gauge that feed intake, comprising following thing Matter and its content:Epiphysin 2.8g, Cobastab61.8g, starch 95g, Icing Sugar 240g, silica 8g, magnesium stearate 2.4g.
4. epiphysin composition according to claim 1, it is characterised in that with 1000 gauge that feed intake, comprising following thing Matter and its content:Epiphysin 2.7g, Cobastab61.9g, starch 98g, Icing Sugar 238g, silica 7.2g, magnesium stearate 2.2g。
5. the preparation method of epiphysin composition according to claim 1, it is characterised in that methods described step includes:
Step one, take epiphysin and Cobastab6Sieve respectively prepared fine powder, and prepared premix A is well mixed with silica;
Step 2, starch sieve prepared starch dust, and prepared premix B is well mixed by equal increments method with premix A;
Step 3, white sugar sieve prepared Icing Sugar, and 30 minutes prepared premix C are mixed with premix B;
Step 4, take magnesium stearate and mix with premix C 15 minutes, total mixed powder is obtained after being well mixed;
After step 5, the inspection of total mixed powder, send into capsule machine filling and capsule is obtained.
6. the preparation method of epiphysin composition according to claim 5, it is characterised in that epiphysin in the step one And Cobastab6Sieve and use 100 mesh sieves.
CN201611094238.0A 2016-12-02 2016-12-02 Melatonin composition and preparation method thereof Pending CN106619617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611094238.0A CN106619617A (en) 2016-12-02 2016-12-02 Melatonin composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611094238.0A CN106619617A (en) 2016-12-02 2016-12-02 Melatonin composition and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106619617A true CN106619617A (en) 2017-05-10

Family

ID=58814109

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611094238.0A Pending CN106619617A (en) 2016-12-02 2016-12-02 Melatonin composition and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106619617A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407761A (en) * 2020-04-28 2020-07-14 广东润源中天生物科技有限公司 Melatonin vitamin B6 tablet and production method thereof
CN114246834A (en) * 2021-12-30 2022-03-29 宣城柏维力生物工程有限公司 Melatonin orally disintegrating preparation for improving sleep and production process thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1416884A (en) * 2002-12-03 2003-05-14 沈阳药科大学 Melatonin composition with soporific effect and its prepn
US20060246129A1 (en) * 2005-04-29 2006-11-02 Linardakis Nikos M Composition for use in treatment of sleep problems and method for same
CN101642455A (en) * 2009-09-04 2010-02-10 芜湖市诺康生物科技有限公司 Nerve-soothing capsule
CN102973561A (en) * 2012-11-23 2013-03-20 西安泰科迈医药科技有限公司 Drug composite for improving sleep and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1416884A (en) * 2002-12-03 2003-05-14 沈阳药科大学 Melatonin composition with soporific effect and its prepn
US20060246129A1 (en) * 2005-04-29 2006-11-02 Linardakis Nikos M Composition for use in treatment of sleep problems and method for same
CN101642455A (en) * 2009-09-04 2010-02-10 芜湖市诺康生物科技有限公司 Nerve-soothing capsule
CN102973561A (en) * 2012-11-23 2013-03-20 西安泰科迈医药科技有限公司 Drug composite for improving sleep and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙艳梅等: "三维荧光光谱结合二阶校正法测定保健品中的褪黑素", 《高等学校化学学报》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111407761A (en) * 2020-04-28 2020-07-14 广东润源中天生物科技有限公司 Melatonin vitamin B6 tablet and production method thereof
CN111407761B (en) * 2020-04-28 2021-06-18 广东润源中天生物科技有限公司 Melatonin vitamin B6 tablet and production method thereof
CN114246834A (en) * 2021-12-30 2022-03-29 宣城柏维力生物工程有限公司 Melatonin orally disintegrating preparation for improving sleep and production process thereof

Similar Documents

Publication Publication Date Title
CN101564163B (en) Food for reducing blood sugar and blood fat and preparation method thereof
CN101810273B (en) Barley nutritional powder and processing method thereof
WO2016015681A1 (en) Specialized flour for nutrition meals for diabetes and preparation method and use thereof
CN108095092A (en) It is a kind of that there is slim generation meal milk shake
CN103609944A (en) Blood pressure reducing and sleeping promoting health-care food
CN103948137B (en) A kind of composite dietary solid beverage and preparation method thereof
CN101991095A (en) Health care product for improving sleep
CN102422950B (en) Hordeum vulgare L. var. nudum hook. f. health tea drink and its processing technology
CN101785544A (en) Production process technology of glutinous rice mulberry cake
CN102669214B (en) Instant nutritive flour containing wheat germ and high dietary fiber and preparation method of instant nutritive flour
CN102578461A (en) Black tartary buckwheat meal replacement powder suitable for diabetics
CN102960604B (en) Xylitol and xanthophyll solid drink and preparation method
CN107319280A (en) A kind of fat-reducing, the meal replacing food of intestinal canal regulating and preparation method thereof
CN106619617A (en) Melatonin composition and preparation method thereof
CN103689202A (en) Formula of maca pollen sugar tablet for women and preparation process thereof
CN102048884A (en) Weight-losing composition containing guarana extract
CN105124669A (en) Gut-purging qi-rectifying oat tartary buckwheat beverage and preparation method thereof
CN104351646A (en) Nutrition and health sorghum noodle and production method thereof
CN107334151A (en) One kind auxiliary reducing blood lipid glad source piece and preparation technology
CN107397032A (en) A kind of fruits and vegetables pressed candy and preparation method thereof
CN105995502A (en) Uncooked cereal food for infants and preparation method of uncooked cereal food
CN107484957A (en) A kind of lecithin red yeast rice particle electuary and method
CN104432057B (en) A kind of health food with endocrine regulation function and preparation method thereof
CN103734594B (en) Sleep-assisting food and processing method thereof
CN102925594A (en) High sweetness sucrose and high sweetness zero calorie sucrose and preparation methods thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170510

RJ01 Rejection of invention patent application after publication